Orlistat 120 mg
The recommended dose of Quick-Slim is one 120-mg capsule three times a day with each main meal containing fat (during or up to 1 hour after the meal).
Gastrointestinal (GI) symptoms were the most commonly observed treatment-emergent adverse events associated with the use of orlistat in the seven double-blind, placebo-controlled clinical trials and are primarily a manifestation of the mechanism of action. (Commonly observed is defined as an incidence of ≥ 5% and an incidence in the orlistat 120 mg group that is at least twice that of placebo).
Drug-drug interaction studies indicate that Quick-Slim had no effect on pharmacokinetics and/or pharmacodynamics of alcohol, digoxin, glyburide, nifedipine (extended-release tablets), oral contraceptives, phenytoin, pravastatin, or warfarin. Alcohol did not affect the pharmacodynamics of orlistat.
Manufactured by Marcyrl